3[1]Marshall L M, Spiegelman D, Barbieri R L, et al. Variation of the incidence of uterine leiomyomata among premenopasual women by ache and race[J]. Obstet gynecol, 1998, 90:967 -973.
4[2]Faerstein E, Szklo M, Rosenshein N B. Risk factors for uterine leiomyoma :a paractice-based case-control study O. AfricanAmerican heritage, reproductive bistort, body size, and smoking[ J ]. Am J Epidemid,2001,153(1): 1 - 10.
5[3]Brosens I, Deprest J, Dalcin P, et al. Clinical significance of cytogenetic abnormalities in uterine myomas [ J ]. Feril Steril,1998,59: 232 - 235.
6[4]Bhugra B, Smolarek T A, Lynch R A, et al. Cloning of a breakpoint cluster region on chromosome 14 in uterine leiomyoma[J]. Cancer Lett, 1998,126:119 - 126.
7[5]Schenmakers E F, Huysmans C, Ven W J. Clinical significance of cytogenetic abnormalities in uterine myomas [ J ]. Cancer Res, 1999,59:19 - 23.
8[6]Quade B J, Weremowicz S, Neskey D M, et al. Fuision transcriprs involving HMGA2 are not a common molecular mechanism in uterine leiomyomata rearrangements in 12q15[J]. Cancer Res,2003,63(6): 1351 - 1358.
9[7]Ven W J. Clinical significance of cytogenetic abnormalities in uterine myomas[ J ]. Obstet Gynecol Reprod Biol, 1998,81 (2):289 - 293.
10[8]Tallmi G, Vanni R, Manfioletti G, et al. Clinical significance of cytogenetic abnormalities in uterine myomas [J]. Lab Znvest,2000,80(3) :359 - 369.
